Lb Pharmaceuticals: Trial Met Primary Endpoint With Statistically Significant Reduction in Panss Total Score at All Dose Levels Vs Placebo
Lb医药:试验在所有剂量水平较安慰剂组实现了主要终点,并在Panss总分上实现了统计学显著降低
Lb Pharmaceuticals: Trial Met Primary Endpoint With Statistically Significant Reduction in Panss Total Score at All Dose Levels Vs Placebo
Lb医药:试验在所有剂量水平较安慰剂组实现了主要终点,并在Panss总分上实现了统计学显著降低
使用浏览器的分享功能,分享给你的好友吧